A Phase II Pilot Trial to Evaluate <i>CoBaT-Y017</i> Safety and Efficacy against Uncomplicated Falciparum Malaria versus Artemether-Lumefantrine in Benin Subjects

<div>Parasitic clearance of <i>CoBaT-Y017</i> versus <i>AL</i>.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: A Phase II Pilot Trial to Evaluate <i>CoBaT-Y017</i> Safety and Efficacy against Uncomplicated Falciparum Malaria versus Artemether-Lumefantrine in Benin Subjects 

Figure 2 | A Phase II Pilot Trial to Evaluate CoBaT-Y017 Safety and Efficacy against Uncomplicated Falciparum Malaria versus Artemether-Lumefantrine in Benin Subjects 